Börse:

Emergent Biosolutions Inc.

[WKN: A0LC2W | ISIN: US29089Q1058]

11,890$ 1,54%

Echtzeit-Aktienkurs Emergent Biosolutions Inc.

Bid: Ask:

Nachrichten zur Emergent Biosolutions Inc. Aktie

» Nachrichtenticker öffnen

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of…

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into…

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and…

Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%

The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…

Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript

EBS earnings call for the period ending December 31, 2023.…

Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript

…

Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation

…

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…